4.5 Article

Structure of the full-length Clostridium difficile toxin B

期刊

NATURE STRUCTURAL & MOLECULAR BIOLOGY
卷 26, 期 8, 页码 712-+

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41594-019-0268-0

关键词

-

资金

  1. National Institute of Health [R01AI139087, R01AI125704, R21AI123920, R21AI139690, R21CA235533, R01GM074830, R01GM130144, R01DK084509, R01AI088748, R01AI132207, U19AI109776, R01 MH081923]
  2. National Institute of General Medical Sciences [P30GM124165]
  3. NIH-ORIP HEI grant [S10 RR029205]
  4. U.S. DOE [DE-AC02-06CH11357]
  5. U.S. DOE, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]
  6. DOE Office of Biological and Environmental Research
  7. National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]

向作者/读者索取更多资源

Clostridium difficile is an opportunistic pathogen that establishes in the colon when the gut microbiota are disrupted by antibiotics or disease. C. difficile infection (CDI) is largely caused by two virulence factors, TcdA and TcdB. Here, we report a 3.87-angstrom-resolution crystal structure of TcdB holotoxin that captures a unique conformation of TcdB at endosomal pH. Complementary biophysical studies suggest that the C-terminal combined repetitive oligopeptides (CROPs) domain of TcdB is dynamic and can sample open and closed conformations that may facilitate modulation of TcdB activity in response to environmental and cellular cues during intoxication. Furthermore, we report three crystal structures of TcdB-antibody complexes that reveal how antibodies could specifically inhibit the activities of individual TcdB domains. Our studies provide novel insight into the structure and function of TcdB holotoxin and identify intrinsic vulnerabilities that could be exploited to develop new therapeutics and vaccines for the treatment of CDI.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据